Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): a study protocol of a prospective, single-arm, phase II trial.

Chen, Jing; Han, Yingyan; Hu, Yingjie; Feng, Xue; Meng, Xiaolin; Guo, Shuaiqingying; Sun, Chaoyang; Chen, Gang; Li, Kezhen

Chen, Jing; Han, Yingyan; Hu, Yingjie; Feng, Xue; Meng, Xiaolin; Guo, Shuaiqingying; Sun, Chaoyang; Chen, Gang; Li, Kezhen.

Afiliação

Chen J; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Han Y; National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Hu Y; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Feng X; National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Meng X; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Guo S; National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Sun C; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Chen G; National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Li K; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.

BMJ Open ; 13(5): e067767, 2023 05 30.

Article em En | MEDLINE | ID: mdl-37253491

Assuntos

Terapia Neoadjuvante; Neoplasias do Colo do Útero; Feminino; Humanos; Terapia Neoadjuvante/métodos; Neoplasias do Colo do Útero/tratamento farmacológico; Neoplasias do Colo do Útero/patologia; Inibidores de Checkpoint Imunológico/uso terapêutico; Estudos Prospectivos; Quimioterapia Adjuvante/métodos; Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos; Quimiorradioterapia/métodos; Quimiorradioterapia Adjuvante; Estadiamento de Neoplasias; Microambiente Tumoral; Ensaios Clínicos Fase II como Assunto

Palavras-chave

CHEMOTHERAPY; Clinical trials; Gynaecological oncology; IMMUNOLOGY

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Terapia Neoadjuvante Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google